...ays contain 60 rabbit tissue samples arrayed on Su...ains 4 unstained slides and 1 hematoxylin and eosi...de contains 15 different tissues from 4 rabbit org.... Each tissue sample (or core) is 1.5 mm in diamet...
...de synthesis with a wide variety of purity levels,...h needs. Purity: IG(>50%), >70%, >80% and >95% ...idues Modifications: Biotin, Fluorescein, N-ace...ids, MAPs, KLH/BSA conjugation, and much more. Se...
Human CALCA EIA (Enzyme immunoassay) Kit, Host: Rabbit ; Extraction-free from BACHEM
... to identify over 150 peptide modifications simult..., protein subsets, and suppress false positives. Y... and relationships easily. The software is ideal f...ression analysis for discovery research. The Parag...
Biology Products:... Research Institute, an affiliate of Harvard Medic...de blood vessel cells that controls angiogenesis (..., is turned on and off by the balance between two ...the use of the same lipid membrane to fulfill oppo.... This finding could lead to new, more targeted dr...
...f "six degrees of separation" emphasized human lin...ow, the same concept provides clues to unraveling ...t genes can cause diseases with very similar chara...ournal Cell, scientists from Baylor College of Med...k of proteins that when perturbed by mutations can...
...en found for the first time in a variety of freshw...nell University researchers. , According to exper...,s College of Veterinary Medicine, the viral hemor... anemia and hemorrhaging in many fish species, was...t to humans. , In May 2006, the researchers, in...
Other Biology News:Schepens scientists are first to discover angiogenesis switch inside blood vessel cells 2Schepens scientists are first to discover angiogenesis switch inside blood vessel cells 3Protein connections: A network to understand disease 2Protein connections: A network to understand disease 3Cornell researchers find serious fish virus in Northeast for first time 2(Date:11/18/2009)... Masimo (Nasdaq: MASI ...re-Through Motion and Low-Perfusion pulse oximetry..., one of the largest healthcare Group Purchasing O...ear purchasing agreement for "gold standard" Masim...rs preferred contract pricing to Uni.H.A.,s 53 mem...
(Date:11/18/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue. ,, Biotechnology Reagents - A Global M...r.com/p0164375/Biotechnology-Reagents---A-Global-M...tm_medium=pr&utm_campaign=prnewswire ,, R... compounds used in a range of biotech related area...
(Date:11/18/2009)...orporation and SwitchGear Genomics announce a nove...ns. , Madison, WI, USA (P... SwitchGear Genomics announce a novel method for c... a study using the HaloCHIP™ System and high...y to correlate DNA binding events to transcription...
(Date:11/18/2009)...duces key cardiac enzymes at multiple time points ...Heart Association 2009 Scientific Sessions , ...ics Inc., a biotechnology company pioneering the d...cs derived from pathogens, today reported results ...(Serp-1), an anti-inflammatory protein derived fro...
Breaking Biology Technology:Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 2Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 3Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 4Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 5Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 6Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 7Reportlinker Adds Biotechnology Reagents - A Global Market Perspective 8Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 2Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 3Viron reports positive Phase II data in Acute Coronary Syndromes (ACS) patients 4